Equities

Optimus Healthcare Services Inc

OHCS:PKL

Optimus Healthcare Services Inc

Actions
  • Price (USD)0.0908
  • Today's Change0.001 / 0.89%
  • Shares traded1.08k
  • 1 Year change-91.75%
  • Beta1.1458
Data delayed at least 15 minutes, as of May 03 2024 19:52 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Optimus Healthcare Services, Inc. is a healthcare company. The Company is focused on creating a network of healthcare companies that advancing access to clinical trial research; and improving and simplifying access to vaccines and pharmaceutical products. The Company provides these services through its portfolio companies, AdhereRx Corporation (PainScript), Clinical Research Alliance, Inc. (CRA), and Worker’s Health Rx (Vaccinations Rx). PainScript’s medical treatment compliance platform is focused on creating a personalized pathway to support chronic care management (CCM) interventions for patients suffering from opioid and other substance use disorders (SUDs). CRA provides community-oriented physicians and hospitals with the necessary infrastructure and support to enroll their patients in clinical trials. CRA provides independent, community-based oncology practices and hospitals in diverse communities with the necessary infrastructure and support to enroll their patients.

  • Revenue in USD (TTM)1.27m
  • Net income in USD-7.79m
  • Incorporated1990
  • Employees17.00
  • Location
    Optimus Healthcare Services Inc1400 Old Westbury RoadSuite 306, Suite 305WESTBURY 11590United StatesUSA
  • Phone+1 (516) 806-4201
  • Websitehttps://www.optimushealthcare.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
NovaBay Pharmaceuticals Inc14.73m-16.70m3.42m24.00--0.7813--0.2324-3.82-3.823.500.29511.162.1610.78613,583.30-75.81-61.51-114.10-83.8953.6159.99-65.46-86.470.9998--0.2555--2.243.32-2.66---15.46--
Aptevo Therapeutics Inc0.00-18.65m3.55m40.00--0.0358-----77.09-70.570.0027.620.00----0.00-63.16-47.16-86.49-85.03-------583.47----0.00---100.00---365.90------
Atreca Inc0.00-97.76m3.58m90.00--0.3322-----2.49-2.490.000.27150.00----0.00-98.54-44.99-116.19-48.05------------0.00------11.13---8.46--
Yield10 Bioscience Inc60.00k-14.46m3.60m29.00------59.97-50.04-50.040.1815-4.950.01--4.002,068.97-241.08-91.26-524.02-108.09-----24,091.67-2,279.74---------86.67-35.94-6.55--1.84--
Biostax Corp0.00-1.65m3.60m-----------0.0198-0.01980.00-0.04560.00-------193.36-75.14---------------8.97--------53.32------
ENDRA Life Sciences Inc0.00-10.06m3.61m21.00--0.5998-----1.93-1.930.000.54470.00----0.00-125.53-132.00-149.91-157.28------------0.005------23.67---19.46--
Optimus Healthcare Services Inc1.27m-7.79m3.63m17.00------2.87-0.1948-0.19480.0317-0.12910.2595--2.1674,453.53-159.79---2,228.37--77.90---615.77--0.1525-15.4121.18--------------
Altamira Therapeutics Ltd0.00-8.03m3.67m10.00--0.3397-----16.35-8.700.004.830.0034.0532.300.00-103.88-73.80-6,364.67-123.19-87.90------1.38-4.370.00------61.02------
Finch Therapeutics Group Inc107.00k-74.75m3.69m18.00--0.1614--34.52-46.59-46.590.066714.250.001--1.49---68.48---74.93-------69,863.55------0.00---87.57--34.80------
Geovax Labs Inc0.00-25.97m3.72m17.00--0.5523-----14.25-14.250.002.910.00----0.00-127.82-108.34-160.47-147.24-------1,842.93----0.00---100.00---85.20------
Livewire Ergogenics Inc67.98k-1.09m3.72m1.00------54.72-0.0061-0.00610.0003-0.00220.19791.742.8667,980.00-317.45-------113.70---1,604.38--0.1248-2.13----68.58---3.64------
Phio Pharmaceuticals Corp0.00-10.83m3.76m8.00--0.3974-----6.40-6.400.002.060.00----0.00-97.63-71.92-116.38-84.15-------253,785.70----0.00------5.70--0.00--
Clearmind Medicine Inc0.00-8.09m3.77m----0.7482-----30.92-30.920.001.590.00-------109.55-218.20-180.61-488.96-----------2.900.0184-------25.03------
Navidea Biopharmaceuticals Inc610.00-8.81m3.83m11.00------6,275.78-0.2086-0.05470.00001-0.03270.00010.15290.006655.45-143.97-169.68---753.52-8,103.2891.34-1,411,062.00-1,938.530.5066-------87.65-48.49-46.75--63.23--
Aditxt Inc645.19k-32.70m3.83m47.00--0.1889--5.94-153.12-153.122.1412.170.02330.89271.3813,727.45-117.12-192.78-251.19-321.59-17.30---5,020.30-7,208.650.2382-4.090.5020---30.90---18.11------
Revelation Biosciences Inc0.00-120.25k3.87m9.000.08090.0943----29.2929.290.0025.130.00----0.00-1.36---3.12--------------0.00------98.89------
Data as of May 03 2024. Currency figures normalised to Optimus Healthcare Services Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.